Institute Group Leaders awarded promotions by the University
We are delighted to announce that several of our Group Leaders have been promoted in the University of Cambridge Senior Academic Promotions.
James Brenton, Sarah Bohndiek and Doug Winton have been promoted to Professors, while Florian Markowetz and Nitzan Rosenfeld have been promoted to Directors of Research. All promotions will take effect from 1 October 2020.
James Brenton
Dr James Brenton has been promoted to Professor of Ovarian Cancer Medicine in the Department of Oncology. Brenton’s research focuses on understanding the molecular complexity of ovarian cancer to improve treatment and patient outcome.
Sarah Bohndiek
Dr Sarah Bohndiek has been promoted to Professor of Biomedical Physics in the Department of Physics. Her group focuses on developing novel imaging approaches that can be applied to understand the role of the tumour microenvironment in cancer progression.
Doug Winton
Dr Doug Winton has been promoted to Professor of Epithelial Biology in the Department of Oncology. His team investigates the cancer cells in the intestinal epithelium to understand the probability of their survival and expansion at each stage and how this varies with different mutations.
Florian Markowetz
Dr Florian Markowetz has been promoted to Director of Research. His team develops computational methods to link genomic profiles with quantitative measures of phenotypes, leading towards a comprehensive systems genetics understanding of cancer.
Nitzan Rosenfeld
Dr Nitzan Rosenfeld has been promoted to Director of Research. Nitzan’s expertise is in liquid biopsy and translational cancer research. His research group has established applications of circulating tumour DNA (ctDNA) sequencing to analyze ctDNA from blood samples of cancer patients.
Related News
See all news-
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
6th December 2024
An MRI-based imaging technique developed at the Institute predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Find out more -
Isabel Esain Garcia awarded PhD Thesis Prize
3rd December 2024
The Prize is awarded annually to a student who has undertaken an outstanding research project to the highest standards during the course of their PhD study at the Cancer Research UK Cambridge Institute.
Find out more -
World first trial to revolutionise treatment of brain cancer
23rd October 2024
A pioneering research study will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer.
Find out more